Results 201 to 210 of about 5,732 (211)

Characterization of Bispecific T-cell Engager (BiTE®) Antibodies with a High-Capacity T-cell Dependent Cellular Cytotoxicity (TDCC) Assay

SLAS Discovery, 2015
Angus M Sinclair
exaly  

GPRC5D-targeted bispecific bolsters T-cell-engager pipeline

Nature Reviews Drug Discovery, 2023
exaly  

COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors

MAbs, 2020
exaly  

Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies

Frontiers in Immunology
Zinnia P Parra-Guillén, Iñaki F Troconiz, Christophe Boëtsch   +2 more
exaly  

Using protein geometry to optimize cytotoxicity and the cytokine window of a ROR1 specific T cell engager

Frontiers in Immunology
Harald Kolmar, Kolmar Harald
exaly  

A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell‐Based Cancer Immunotherapy

Advanced Materials
Yumiao Chen, Yinghao Ding, Zhimou Yang   +2 more
exaly  

Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine

Molecular Therapy
Saru Basnet, Anna Kanerva, Santeri Pakola   +2 more
exaly  

CD19xCD3 T cell engager blinatumomab effective in refractory generalized myasthenic syndromes

Molecular Therapy
Niklas Hüntemann
exaly  

Enhancing T cell cytotoxicity in multiple myeloma with bispecific αPD-L1 × αCD3 T cell engager-armed T cells and low-dose bortezomib therapy

Biomedicine and Pharmacotherapy
Nunghathai Sawasdee, Chutamas Thepmalee, Mutita Junking   +2 more
exaly  

Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer

Advanced Science
YÜ-CHÜAN Lin, Mei-Chih Chen, Shi-wei Huang   +2 more
exaly